Audentes Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) – PRNewswire

This post was originally published on this site

Audentes Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)  PRNewswire

SAN FRANCISCO, Dec. 7, 2018 /PRNewswire/ — Audentes Therapeutics, Inc. (Nasdaq: BOLD), a biotechnology company focused on developing and …

Leave a Reply